ANIXAnixa Biosciences Inc

Nasdaq anixa.com


$ 3.01 $ -0.08 (-2.59 %)    

Thursday, 02-May-2024 12:16:30 EDT
QQQ $ 424.25 $ -0.90 (-0.21 %)
DIA $ 380.44 $ -1.08 (-0.28 %)
SPY $ 502.38 $ -2.02 (-0.4 %)
TLT $ 88.70 $ 0.48 (0.54 %)
GLD $ 212.86 $ 0.40 (0.19 %)
$ 3.09
$ 3.05
$ 0.00 x 0
$ 0.00 x 0
$ 3.01 - $ 3.05
$ 2.75 - $ 5.13
58,633
na
98.57M
$ 0.69
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-12-2024 01-31-2024 10-Q
2 01-16-2024 10-31-2023 10-K
3 09-06-2023 07-31-2023 10-Q
4 06-14-2023 04-30-2023 10-Q
5 03-17-2023 01-31-2023 10-Q
6 01-04-2023 10-31-2022 10-K
7 09-09-2022 07-31-2022 10-Q
8 06-10-2022 04-30-2022 10-Q
9 03-11-2022 01-31-2022 10-Q
10 01-04-2022 10-31-2021 10-K
11 09-01-2021 07-31-2021 10-Q
12 06-10-2021 04-30-2021 10-Q
13 03-11-2021 01-31-2021 10-Q
14 01-07-2021 10-31-2020 10-K
15 09-08-2020 07-31-2020 10-Q
16 06-09-2020 04-30-2020 10-Q
17 03-09-2020 01-31-2020 10-Q
18 01-09-2020 10-31-2019 10-K
19 09-06-2019 07-31-2019 10-Q
20 06-12-2019 04-30-2019 10-Q
21 03-13-2019 01-31-2019 10-Q
22 01-11-2019 10-31-2018 10-K
23 09-07-2018 07-31-2018 10-Q
24 06-11-2018 04-30-2018 10-Q
25 03-09-2018 12-01-2017 10-Q
26 01-09-2018 10-31-2017 10-K
27 09-08-2017 07-31-2017 10-Q
28 05-26-2017 04-30-2017 10-Q
29 03-16-2017 01-31-2017 10-Q
30 12-07-2016 10-31-2016 10-K
31 08-19-2016 07-31-2016 10-Q
32 05-20-2016 04-30-2016 10-Q
33 02-19-2016 01-31-2016 10-Q
34 12-23-2015 10-31-2015 10-K
35 08-18-2015 07-31-2015 10-Q
36 05-22-2015 04-30-2015 10-Q
37 03-09-2015 01-31-2015 10-Q
38 01-29-2015 10-31-2014 10-K
39 09-15-2014 07-31-2014 10-Q
40 06-16-2014 04-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-12-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

 hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-12-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

 anixa-biosciences-initiates-dosing-in-second-cohort-of-ovarian-cancer-car-t-clinical-trial

 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a clinical-stage biotechnology company focus...

 anixa-biosciences-announces-japanese-patent-on-ovarian-cancer-vaccine-technology

Broad coverage extended to Japan and related regionsSAN JOSE, Calif., Jan. 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. (&#...

 anixa-biosciences-reveals-updated-data-from-breast-cancer-vaccine-trial-says-exceeded-expectations

Anixa Biosciences Inc (NASDAQ: ANIX) announced new and updated results from the Phase 1 trial of its breast cancer vaccine. 

 hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-12-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

 anixa-biosciences-to-host-conference-call-this-evening-to-discuss-new-data-from-ongoing-phase-1-study-of-breast-cancer-vaccine

– Data to be released at approximately 6:00 p.m. ET, following presentation at 2023 SABCS –– Conference call to commence at 6:3...

 anixa-biosciences-announces-european-patent-on-ovarian-cancer-vaccine-technology

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatm...

 anixa-biosciences-completes-treatment-of-first-patient-cohort-in-ovarian-cancer-car-t-clinical-trial

- With no dose-limiting toxicities observed, treatment of second dose cohort to beginSAN JOSE, Calif., Oct. 13, 2023 /PRNewswir...

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 647 companies set new 52-week lows.

 anixa-biosciences-announces-issuance-of-additional-us-patent-for-ovarian-cancer-vaccine-technology

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatm...

 hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-12-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

 hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-12-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

 anixa-biosciences-announces-invited-presentation-on-ovarian-cancer-car-t-therapy-at-the-8th-annual-car-tcr-summit

 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treat...

Core News & Articles

 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treat...

 hc-wainwright--co-reiterates-buy-on-anixa-biosciences-maintains-12-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION